post transplant care | Steris Healthcare Pvt Ltd, Mumbai

Mumbai 08042755542 info@sterispharma.com

Chat with us

This is your website preview.

Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360 android app / iOS App / web portal.

{ "products": [ { "_id": "69cbc41faf13b43636b170d0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Everolimus Tablets 0.5 mg", "description": "EVERENOLIMUS 0.5 is a prescription medication containing Everolimus 0.5 mg tablets, a potent mTOR (mammalian target of rapamycin) inhibitor used in advanced medical treatments. This medicine works by regulating cell growth, division, and immune system activity, making it effective in both oncology and transplant care.\nEverolimus has become a crucial therapeutic option for patients requiring targeted cancer therapy or immunosuppression after organ transplantation. Its dual functionality—controlling abnormal cell proliferation and preventing organ rejection—makes it a preferred choice among healthcare providers.\nIn India, EVERENOLIMUS 0.5 is increasingly prescribed for specific cancers, post-transplant care, and rare disorders like tuberous sclerosis complex. Its oral tablet form allows convenient administration while maintaining effective systemic action.\n\nUses of EVERENOLIMUS 0.5\n\nEVERENOLIMUS 0.5 is indicated for a range of serious medical conditions:\n1. Organ Transplantation\nHelps prevent rejection of kidney and liver transplants\nMaintains graft survival by suppressing the immune response\n2. Cancer Treatment\nHormone receptor-positive, HER2-negative advanced breast cancer\nAdvanced kidney cancer (renal cell carcinoma)\nNeuroendocrine tumors (pancreas, lungs, gastrointestinal tract)\n3. Tuberous Sclerosis Complex (TSC)\nManages non-cancerous tumors such as subependymal giant cell astrocytoma (SEGA)\nReduces tumor growth in vital organs\n4. Other Rare Conditions\nCertain types of cardiac or renal vascular growth disorders, under specialist supervision\nBenefits of EVERENOLIMUS 0.5\n1. Dual Therapeutic Action\nOffers immunosuppressive benefits for transplant patients\nProvides targeted anti-cancer activity to control abnormal cell growth\n2. Improved Transplant Outcomes\nReduces the risk of graft rejection\nEnsures long-term functionality of transplanted organs\n3. Targeted Cancer Therapy\nFocuses on specific cellular pathways\nMinimizes damage to healthy cells compared to conventional chemotherapy\n4. Slows Disease Progression\nEffective in advanced cancers and benign tumors\nControls disease symptoms and improves patient quality of life\n5. Convenient Oral Formulation\nEasy to take as a tablet without injections\nEnables consistent and controlled drug delivery\n6. Enhances Long-Term Management\nRegular use supports chronic disease control\nReduces hospitalization and complication rates\nDosage of EVERENOLIMUS 0.5\n\nThe exact dosage depends on the patient’s condition, weight, and response to therapy. It must be determined by a healthcare professional.\n\nGeneral Guidelines:\nTypically taken once daily\nSwallow the tablet whole with water\nCan be taken with or without food, but maintain consistency\nMonitoring Requirements:\nRegular blood tests to check kidney and liver function\nMonitoring drug levels ensures effectiveness and safety\nMissed Dose:\nTake the missed dose as soon as possible\nIf it is near the next scheduled dose, skip the missed dose\nDo not double the dose\n\nSide Effects of EVERENOLIMUS 0.5\n\nEVERENOLIMUS 0.5 may cause side effects, which can range from mild to serious.\nCommon Side Effects:\nFatigue and weakness\nNausea or vomiting\nMouth ulcers\nDiarrhea\nLess Common Side Effects:\nEdema (swelling in hands or feet)\nIncreased blood sugar and cholesterol levels\nSkin rash\nSerious Side Effects:\nIncreased risk of infections due to suppressed immunity\nLung inflammation (non-infectious pneumonitis)\nImpaired kidney or liver function\nDelayed wound healing\nWhen to Seek Medical Attention:\nPersistent fever or signs of infection\nShortness of breath or chest pain\nSevere weakness, dizziness, or swelling\nUnusual bleeding or bruising\nPrecautions and Warning\n1. Infection Risk\nSuppressed immunity increases susceptibility to infections\nAvoid exposure to people with contagious diseases\n2. Liver and Kidney Function\nRegular tests are necessary to monitor organ health\n3. Vaccinations\nAvoid live vaccines during treatment\nConsult your doctor before any vaccination\n4. Drug Interactions\nInform your doctor about all medications, including antibiotics, antifungals, and supplements\n5. Pregnancy and Contraception\nNot recommended during pregnancy\nEffective contraception is advised during and after treatment\n6. Surgery and Wound Healing\nInform your doctor before undergoing surgery\nWound healing may be delayed due to Everolimus effects\n7. Sun Protection\nIncreased sensitivity to sunlight\nUse sunscreen and protective clothing\n\nConclusion\n\nEVERENOLIMUS 0.5 (Everolimus Tablets 0.5 mg) is a highly effective oral medication that offers dual benefits for cancer patients and organ transplant recipients. Its targeted mechanism ensures precise therapeutic action while minimizing unnecessary side effects.\nBy preventing organ rejection, controlling tumor growth, and improving long-term outcomes, EVERENOLIMUS 0.5 has become a trusted choice in modern clinical practice. Patients in India seeking reliable, medically supervised care for complex conditions can benefit greatly from this advanced therapy.\nStrict adherence to dosage, regular monitoring, and medical supervision are essential for safe and effective use. Combined with lifestyle and dietary guidance, EVERENOLIMUS 0.5 supports improved quality of life and enhanced clinical outcomes.", "price": 643.0, "discountamount": 193.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2359, "imageuri": "https://productimages.withfloats.com/actual/69cbc421595f848aedb0807c.png", "tileimageuri": "https://productimages.withfloats.com/tile/69cbc421595f848aedb0807c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-03-31T12:54:55.448Z", "updatedon": "2026-04-14T12:54:29.458Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/everolimus-tablets-0-5-mg/2359", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "EVERENOLIMUS 0.5", "category": "Oncology", "tags": [ "everolimus tablets 0.5 mg uses", "everolimus 0.5 mg dosage and benefits", "everolimus 0.5 mg side effects and precautions", "everolimus 0.5 mg mechanism of action", "everolimus 0.5 mg tablet guide", "everolimus 0.5 mg price in India", "everolimus tablets bulk supplier", "best everolimus tablets 0.5 mg price and uses India", "buy everolimus 0.5 mg tablets online at best price", "everolimus tablets for organ transplant patients India" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "693c0a0eb7439f8802544bc8", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "RIBAVIRIN CAPSULES IP 100mg", "description": "REBATERIS 100 contains Ribavirin IP 100mg in a hard gelatin capsule filled with white to off-white powder for optimal stability and bioavailability. Each pack typically includes 30 capsules, designed for oral administration with food to enhance absorption and reduce gastrointestinal upset. Ribavirin, a synthetic guanosine nucleoside analog, interferes with viral RNA polymerase and mRNA capping, halting hepatitis C virus (HCV) replication at multiple stages. This broad-spectrum antiviral also shows activity against respiratory syncytial virus (RSV) in select pediatric cases, though its primary indication remains HCV genotype management.\n\nThe 100mg strength allows for weight-based dosing adjustments, making REBATERIS 100 suitable for adults and children over 3 years under specialist supervision. Unlike higher 200mg capsules, it supports finer dose reductions during therapy to manage side effects, ensuring better tolerability. Stored at room temperature away from moisture, it maintains potency for extended shelf life, aligning with pharmacopeial standards for purity and dissolution.\n\nKey Uses\nREBATERIS 100 treats chronic hepatitis C virus infection in combination therapies, particularly for patients ineligible for all-oral direct-acting antivirals. It boosts sustained virologic response rates when paired with pegylated interferon alfa, addressing genotypes 1 through 6 based on regional guidelines.\n\nIn severe RSV lower respiratory tract infections, off-label use occurs in hospitalized infants, where aerosolized forms predominate, but oral REBATERIS 100 contributes to interferon combos for immunocompromised children. It curbs viral load, prevents liver fibrosis progression, and reduces cirrhosis risk, making it essential for long-term liver preservation.\n\nAdditionally, emerging evidence supports its adjunct role in certain hemorrhagic fevers like Lassa virus, though availability limits widespread application. Always initiated by hepatologists, treatment durations span 24-48 weeks depending on genotype, viral load, and response milestones.\n\nMajor Benefits\nREBATERIS 100 enhances viral clearance, achieving up to 50-80% sustained response rates in interferon combinations, significantly lowering hepatocellular carcinoma risk over five years. Patients experience normalized liver enzymes and fibrosis regression on biopsy follow-up.\n\nIts oral capsule form simplifies adherence compared to injectables, with twice-daily dosing fitting daily routines. The 100mg potency permits precise titration—e.g., 800-1400mg daily divided—for personalized therapy, minimizing excess exposure in lighter patients.\n\nLong-term, it preserves liver function, averting transplants and improving quality of life metrics like fatigue reduction and work productivity. Cost-effective for resource-limited settings, REBATERIS 100 bridges gaps until pan-genotypic regimens become accessible.\nBenefit\tMechanism\tClinical Impact\nViral Suppression\tRNA polymerase inhibition \t>50% SVR in combos \nLiver Protection\tFibrosis halt \tReduced cirrhosis by 30-40%\nFlexible Dosing\t100mg increments \tBetter tolerability, adherence\nBroad Genotype Coverage\tMulti-genotype efficacy \tVersatile for diverse patients\nPotential Side Effects\nCommon side effects include hemolytic anemia, peaking at weeks 4-8, necessitating hemoglobin monitoring and dose cuts to 600mg daily if levels drop below 10g/dL. Fatigue, headache, and insomnia affect over 40% of users, often resolving post-therapy.\n\nGastrointestinal issues like nausea, diarrhea, and anorexia occur in 20-30%, mitigated by food intake. Dermatologic reactions—rash, pruritus—or flu-like symptoms from interferon pairing demand vigilance. Teratogenicity risks are high; dual contraception is mandatory for 6 months post-treatment due to sperm/ovum mutagenicity.\n\nSerious risks encompass pulmonary infiltrates, cardiac ischemia in vulnerable patients, and thyroid dysfunction. Avoid in hemoglobinopathies, severe renal impairment (CrCl <50mL/min), or pregnancy. Regular blood counts and ophthalmologic exams guide safe continuation.\n\nDosage Guidelines\nDosing is weight-based: adults <75kg receive mg/day (10 capsules: 5 AM, 5 PM); ≥75kg get 1200 mg/day (12 capsules: 6 AM, 6 PM), swallowed whole with meals. Pediatrics (≥3 years): 15mg/kg/day divided BID, rounded to the nearest 100mg via REBATERIS 100 capsules.\n\nReduce by 200-400mg for anemia or neutropenia; discontinue if unresolved. Duration: 48 weeks for genotype 1, 24 weeks for others, with viral load checks at week 12. Swallow intact; no crushing.\nConclusion\nREBATERIS 100 empowers hepatitis C management with proven antiviral potency and dosing precision from Steris Healthcare. It transforms prognosis for countless patients, but demands specialist oversight amid monitoring needs", "price": 2900.0, "discountamount": 870.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2242, "imageuri": "https://productimages.withfloats.com/actual/693c0a151c130ff8f4cd2c93.png", "tileimageuri": "https://productimages.withfloats.com/tile/693c0a151c130ff8f4cd2c93.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-12T12:26:54.651Z", "updatedon": "2026-04-22T05:52:37.835Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//ribavirin-capsules-ip-100mg/2242", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "REBATERIS 100", "category": "GASTROLOGYRANGE", "tags": [ "Ribavirin IP 100mg", "ribavirin capsules ip 100 mg", "ribavirin 100 mg capsules", "ribavirin capsules 100 mg ip", "ribavirin ip capsules 100mg", "ribavirin 100 mg medicine", "ribavirin capsules 100 mg uses", "ribavirin capsules 100 mg side effects", "ribavirin capsules dosage 100 mg", "ribavirin capsules ip 100 mg composition", "how ribavirin capsules work", "ibavirin antiviral medicine 100 mg", "ribavirin capsules ip 100 mg", "ribavirin 100 mg capsules", "ribavirin ip 100 mg capsule uses", "ribavirin capsules 100 mg price in india", "ribavirin ip capsules dosage", "ribavirin capsules ip composition", "what is ribavirin capsules ip 100 mg used for", "ribavirin 100 mg capsule how it works", "ribavirin capsules ip 100 mg benefits", "ribavirin capsules ip side effects", "ribavirin 100 mg capsule dosage guidelines", "ribavirin capsules ip mechanism of action", "ribavirin capsules ip 100 mg manufacturer india", "ribavirin capsules ip wholesale price", "ribavirin capsules ip generic name", "ribavirin capsules ip substitute brands" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6908575f0c31b1295dc50d7e", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Ursodeoxycholic Acid 600 mg", "description": "Ursodeoxycholic Acid 600 mg is a clinically trusted and widely prescribed medication used in the management of liver and gallbladder disorders. Belonging to the class of bile acid derivatives, it plays a vital role in improving liver function and dissolving certain types of gallstones without surgery. This medicine is commonly prescribed to patients suffering from cholestatic liver diseases, such as primary biliary cholangitis (PBC), non-alcoholic fatty liver disease (NAFLD), and bile reflux gastritis.\n\nIn the Indian healthcare setting, Ursodeoxycholic Acid (also known as UDCA) has become a cornerstone therapy for liver protection. It is known not only for its effectiveness in improving bile flow but also for its anti-inflammatory, immunomodulatory, and cytoprotective properties. The 600 mg strength formulation provides an optimal dose for adult patients, ensuring consistent bile regulation and liver cell protection.\n\nProduced under stringent quality control by leading pharmaceutical companies like Steris Healthcare Pvt. Ltd., Ursodeoxycholic Acid 600 mg ensures purity, efficacy, and patient safety. This makes it a dependable choice for clinicians and patients managing chronic liver diseases in India.\n\nWhat is Ursodeoxycholic Acid?\n\nUrsodeoxycholic Acid (UDCA) is a naturally occurring bile acid that is present in small amounts in the human body. It is synthesized and used as a medication to treat liver and gallbladder conditions by altering bile composition and reducing the production of toxic bile acids.\n\nChemically, Ursodeoxycholic Acid is a hydrophilic bile acid, meaning it has a high affinity for water and helps replace harmful hydrophobic bile acids that can damage liver cells. It is known for its ability to protect hepatocytes (liver cells) from injury, enhance bile secretion, and dissolve cholesterol-based gallstones.\n\nBy reducing bile cholesterol saturation and promoting bile flow, UDCA helps maintain liver function, especially in conditions where bile flow is obstructed or impaired.\n\nMechanism of Action\n\nThe therapeutic action of Ursodeoxycholic Acid is multifaceted:\n\nBile Flow Regulation:\nUDCA improves bile secretion and reduces bile stasis (retention). This helps in clearing toxic bile acids from the liver, thereby preventing inflammation and fibrosis.\n\nCytoprotective Effect:\nIt stabilizes the hepatocyte (liver cell) membrane and reduces damage caused by bile acid-induced oxidative stress.\n\nImmunomodulatory Action:\nUrsodeoxycholic Acid reduces autoimmune destruction of bile ducts in diseases like primary biliary cholangitis by modulating immune response.\n\nCholesterol Reduction:\nUDCA decreases the cholesterol content of bile and suppresses hepatic cholesterol synthesis, leading to the gradual dissolution of cholesterol gallstones.\n\nAntifibrotic and Anti-inflammatory Role:\nBy reducing inflammation and fibrosis markers, UDCA helps slow the progression of chronic liver diseases.\n\nTherapeutic Uses of Ursodeoxycholic Acid 600 mg\n\nUrsodeoxycholic Acid 600 mg tablets are prescribed for a wide range of liver and gallbladder-related conditions. Below are the major medical indications:\n\n1. Primary Biliary Cholangitis (PBC):\n\nOne of the most common uses of UDCA is in treating primary biliary cholangitis, an autoimmune condition that causes slow, progressive destruction of bile ducts within the liver. Ursodeoxycholic Acid helps improve bile flow, reduce bilirubin levels, and delay the need for liver transplantation in many patients.\n\n2. Cholestatic Liver Diseases:\n\nIt is used to treat cholestatic conditions where bile secretion is impaired, such as:\n\nIntrahepatic cholestasis during pregnancy\n\nDrug-induced cholestasis\n\nChronic cholestatic hepatitis\n\nPost-surgical biliary obstruction\n\n3. Gallstone Dissolution (Cholesterol Gallstones):\n\nUrsodeoxycholic Acid 600 mg is effective in dissolving small, non-calcified cholesterol gallstones in patients who cannot undergo surgery. It works by reducing cholesterol saturation in bile, gradually breaking down gallstones over several months.\n\n4. Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH):\n\nIn patients with fatty liver or metabolic liver disorders, UDCA helps improve liver enzyme levels and reduces oxidative stress, supporting better liver health.\n\n5. Bile Reflux Gastritis:\n\nUDCA is used to relieve symptoms caused by bile reflux into the stomach, such as epigastric pain, bloating, and nausea.\n\n6. Cystic Fibrosis-Related Liver Disease:\n\nIt can be used to improve bile flow and prevent hepatic complications in patients with cystic fibrosis.\n\n7. Post Liver Transplantation:\n\nUDCA is sometimes used as supportive therapy to prevent graft-related cholestasis and maintain optimal liver function after transplantation.\n\nKey Benefits of Ursodeoxycholic Acid 600 mg\n1. Promotes Healthy Liver Function\n\nUrsodeoxycholic Acid supports liver detoxification and enhances bile secretion, reducing bile stasis and protecting hepatocytes from toxic damage.\n\n2. Dissolves Cholesterol Gallstones Naturally\n\nUnlike surgical interventions, UDCA provides a non-invasive way to dissolve cholesterol gallstones, especially in patients unfit for surgery.\n\n3. Protects Liver Cells from Damage\n\nUDCA stabilizes the hepatocyte membrane and reduces cell injury caused by bile acids, alcohol, or medications.\n\n4. Reduces Inflammation and Fibrosis\n\nIts anti-inflammatory and antifibrotic properties help slow down the progression of chronic liver diseases.\n\n5. Regulates Cholesterol Levels\n\nUrsodeoxycholic Acid lowers bile cholesterol concentration, which helps maintain a balanced lipid profile and prevents gallstone formation.\n\n6. Supports Recovery in Liver Disorders\n\nIn patients with hepatitis, fatty liver, or cirrhosis, UDCA helps improve liver enzyme levels (ALT, AST, ALP), signaling better liver recovery.\n\n7. Improves Digestive Function\n\nBy improving bile flow, UDCA enhances fat digestion and reduces symptoms like bloating, nausea, and postprandial discomfort.\n\n8. Safe for Long-Term Use\n\nWhen prescribed under medical supervision, Ursodeoxycholic Acid 600 mg is well-tolerated and safe for prolonged treatment of chronic liver diseases.\n\nDosage and Administration\n\nRecommended Dose: The typical adult dose of Ursodeoxycholic Acid ranges between 8–12 mg per kilogram of body weight per day, which equals about 600 mg once or twice daily depending on the patient’s condition.\n\nFormulation: Tablet form (Ursodeoxycholic Acid 600 mg)\n\nMode of Administration: Oral\n\nTiming: It should be taken with meals to enhance absorption and reduce gastrointestinal side effects.\n\nTreatment Duration:\n\nFor gallstone dissolution, therapy may last for 6 months to 2 years.\n\nFor chronic liver conditions, treatment may be long-term or lifelong under physician guidance.\n\nImportant Note:\nThe dosage should be individualized based on body weight, liver function, and medical condition. Patients must not self-medicate and should take the medicine only as prescribed by a healthcare professional.\n\nPrecautions and Warnings\n\nBefore using Ursodeoxycholic Acid 600 mg, patients should consider the following precautions:\n\nMedical Supervision Required:\nAlways use this medicine under the guidance of a doctor, particularly if you have a history of severe liver or gallbladder disease.\n\nAvoid in Certain Gallstones:\nUDCA is not effective for calcified or pigment gallstones.\n\nPregnancy and Breastfeeding:\nWhile UDCA is considered relatively safe during pregnancy, it should only be used when prescribed by a physician. Minimal amounts may pass into breast milk.\n\nMonitor Liver Function:\nRegular liver function tests (LFTs) are advised during treatment to monitor therapeutic response and liver health.\n\nDrug Interactions:\nAvoid concurrent use with:\n\nAluminum-based antacids (reduce UDCA absorption)\n\nCholestyramine or Colestipol (interfere with bile acid absorption)\n\nCiclosporin or Estrogens (may alter bile composition)\n\nAlcohol Consumption:\nAlcohol can strain the liver and reduce the effectiveness of UDCA therapy. Patients should limit or avoid alcohol during treatment.\n\nGastrointestinal Disorders:\nUse with caution in patients with peptic ulcer, severe diarrhea, or gastrointestinal inflammation.\n\nPossible Side Effects of Ursodeoxycholic Acid 600 mg\n\nUrsodeoxycholic Acid is generally well-tolerated, but some patients may experience mild to moderate side effects. These are typically temporary and improve as the body adjusts to the medication.\n\nCommon Side Effects:\n\nDiarrhea or loose stools\n\nNausea and vomiting\n\nAbdominal discomfort\n\nIndigestion or bloating\n\nHeadache\n\nDizziness\n\nLess Common Side Effects:\n\nRash or itching (urticaria)\n\nIncreased liver enzymes (temporary)\n\nBack pain or joint pain\n\nCough or upper respiratory infection symptoms\n\nRare but Serious Side Effects:\n\nSevere right upper abdominal pain (may indicate gallstone complications)\n\nJaundice or dark urine (signs of liver stress)\n\nPersistent diarrhea or dehydration\n\nAllergic reaction (swelling, rash, or shortness of breath)\n\nNote:\nIf any of these side effects persist or worsen, it is important to inform your doctor immediately. Never stop or alter the dosage without consulting your healthcare provider.\n\nSafety in Special Populations\nPregnancy:\n\nUDCA is sometimes used to treat intrahepatic cholestasis of pregnancy (ICP) under strict medical supervision. While generally safe, dosage adjustment and monitoring are essential.\n\nLactation:\n\nIt is considered safe in breastfeeding mothers as minimal quantities are excreted into breast milk.\n\nElderly Patients:\n\nNo specific dosage adjustment is needed, but liver function should be monitored regularly.\n\nChildren:\n\nUrsodeoxycholic Acid can be prescribed in pediatric doses for liver-related disorders, particularly biliary atresia, under pediatric supervision.\n\nStorage and Handling\n\nStore in a cool, dry place below 25°C.\n\nProtect from moisture and direct sunlight.\n\nKeep out of reach of children.\n\nDo not use after the expiry date printed on the pack.\n\nClinical Efficacy and Research Insights\n\nClinical studies across India and globally have confirmed the efficacy of Ursodeoxycholic Acid in managing chronic liver and biliary diseases. Long-term use of UDCA has shown:\n\nImprovement in liver enzyme profiles (AST, ALT, ALP).\n\nReduction in bilirubin levels in cholestatic conditions.\n\nDelay in disease progression in primary biliary cholangitis.\n\nReduction in gallstone size and formation rate with consistent therapy.\n\nBetter quality of life scores among patients with chronic liver conditions.\n\nIts established safety profile and biochemical benefits make Ursodeoxycholic Acid a cornerstone therapy in hepatology.\n\nLifestyle and Dietary Recommendations During Treatment\n\nTo enhance the effectiveness of UDCA therapy and support liver health, patients are advised to:\n\nMaintain a Balanced Diet:\nInclude fresh fruits, vegetables, whole grains, and lean proteins. Avoid fatty, fried, and processed foods.\n\nStay Hydrated:\nDrink sufficient water to aid digestion and toxin elimination.\n\nLimit Alcohol and Caffeine:\nBoth can strain liver metabolism and interfere with medication effectiveness.\n\nExercise Regularly:\nModerate physical activity helps improve liver function and reduce fat accumulation.\n\nAvoid Self-Medication:\nConsult your doctor before using any over-the-counter supplements or herbal products.\n\nFrequently Asked Questions (FAQs)\n\nQ1. How long should Ursodeoxycholic Acid 600 mg be taken?\nThe duration depends on your condition. For gallstone dissolution, treatment may last 6–24 months. For chronic liver diseases, long-term therapy may be recommended.\n\nQ2. Can Ursodeoxycholic Acid cure liver disease completely?\nWhile it does not cure liver disease, UDCA can slow its progression, protect liver cells, and improve biochemical and clinical outcomes.\n\nQ3. Can I take Ursodeoxycholic Acid on an empty stomach?\nIt is best taken with food to enhance absorption and minimize stomach upset.\n\nQ4. Does it interact with other medications?\nYes. Antacids, cholesterol-binding resins, and estrogens may interfere with UDCA absorption or activity. Always inform your doctor about all medications you’re taking.\n\nQ5. How long does it take to see results?\nLiver function improvement can often be observed within a few weeks, but gallstone dissolution may take several months of consistent use.\n\nConclusion\n\nUrsodeoxycholic Acid 600 mg is a trusted and clinically validated therapy for various liver and gallbladder conditions. Its unique ability to enhance bile flow, protect liver cells, and dissolve cholesterol gallstones makes it an indispensable part of hepatology treatment protocols.", "price": 1385.0, "discountamount": 415.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2195, "imageuri": "https://productimages.withfloats.com/actual/69099314f017379146dfffdc.png", "tileimageuri": "https://productimages.withfloats.com/tile/69099314f017379146dfffdc.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-11-03T07:18:55.866Z", "updatedon": "2026-03-12T11:04:38.325Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//ursodeoxycholic-acid-600-mg/2195", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "UDCHOLIC 600 SR", "category": "GASTROLOGYRANGE", "tags": [ "ursodeoxycholic acid 600 mg", "ursodeoxycholic acid tablets 600 mg", "ursodeoxycholic acid 600 mg uses", "ursodeoxycholic acid 600 mg dosage", "what is ursodeoxycholic acid 600 mg", "how ursodeoxycholic acid works", "ursodeoxycholic acid used for liver disease", "ursodeoxycholic acid for gallstones treatment", "ursodeoxycholic acid benefits for liver", "ursodeoxycholic acid for fatty liver", "ursodeoxycholic acid 600 mg price in india", "ursodeoxycholic acid 600 mg tablet brands", "buy ursodeoxycholic acid 600 mg online", "best ursodeoxycholic acid tablets 600 mg", "what is ursodeoxycholic acid 600 mg used for", "how long to take ursodeoxycholic acid", "does ursodeoxycholic acid cure fatty liver" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66d6df52731125bdd4e1003b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VALGANCICLOVIR TABLET 450 MG", "description": "VOLANE SOURCE 450 is a pharmaceutical tablet containing Valganciclovir at a dosage strength of 450 mg. It is a potent antiviral medication primarily designed to treat and prevent certain viral infections caused by cytomegalovirus (CMV), especially in immunocompromised patients such as those undergoing organ transplants or living with HIV/AIDS. Manufactured adhering to strict quality standards under the tablet IP (Indian Pharmacopoeia), VOLANE SOURCE 450 ensures consistent efficacy and safety for patients requiring antiviral therapy.\n\nComposition and Pharmacological Profile\nEach film-coated tablet of VOLANE SOURCE 450 contains 450 mg of Valganciclovir as the active ingredient. Valganciclovir is a prodrug of ganciclovir, meaning it is converted in the body into ganciclovir, which is the active antiviral agent. Its mechanism involves inhibiting viral DNA synthesis by competing with deoxyguanosine triphosphate for incorporation into viral DNA, thereby suppressing the replication of CMV and related herpes viruses.\n\nPrimary Uses of VOLANE SOURCE 450\nTreatment of CMV Retinitis: CMV retinitis is a serious viral eye infection common in patients with weakened immune systems, such as AIDS patients. It leads to inflammation and possible vision loss if left untreated. VOLANE SOURCE 450 is a frontline therapy used to halt the progression of this infection.\n\nPrevention of CMV Disease in Transplant Patients: Solid organ transplant recipients and bone marrow transplant patients are at high risk of CMV infection due to immunosuppressive drugs. Prophylactic use of VOLANE SOURCE 450 helps in preventing CMV disease in these vulnerable groups.\n\nTreatment of CMV Infection: Apart from retinitis, CMV can cause systemic infections affecting multiple organs, including lungs, digestive tract, and nervous system. VOLANE SOURCE 450 is used for managing such infections effectively.\n\nPart of Combination Therapy: It may also be prescribed alongside other antiviral agents as part of combination treatment protocols tailored to complex viral infections, enhancing viral suppression.\n\nKey Benefits of Using VOLANE SOURCE 450\nHigh Oral Bioavailability: Being a prodrug, Valganciclovir is well absorbed orally and converted efficiently to ganciclovir in the body, enabling effective antiviral levels.\n\nWide Spectrum of Action: Targets multiple herpesviruses with high specificity, primarily cytomegalovirus, reducing viral load and infection severity.\n\nReduced Risk of CMV Disease Post-Transplant: By preventing CMV infection in transplant recipients, VOLANE SOURCE 450 significantly lowers the risk of post-transplant complications related to viral disease.\n\nConvenient Oral Dosage: Unlike intravenous ganciclovir, VOLANE SOURCE 450 allows for easier home administration, improving patient compliance and quality of life.\n\nEffective Against Resistant Strains: Used in recurrent and resistant CMV infections, especially where other therapies fail.\n\nProtects Vision: In CMV retinitis patients, prompt use of VOLANE SOURCE 450 can preserve vision and prevent blindness due to viral damage.\n\nRecommended Dosage and Administration\nThe dosing of VOLANE SOURCE 450 depends on the condition being treated, kidney function, and patient immune status. It is typically prescribed by healthcare professionals following careful medical assessment.\n\nFor CMV retinitis treatment, the initial dose is usually higher and then tapered down for maintenance.\n\nFor CMV prophylaxis post-transplant, a standard dose is taken once or twice daily for several months.\n\nIt is advised to swallow tablets whole with food to enhance absorption.\n\nRegular monitoring of blood counts and kidney function is essential during therapy since the drug can impact bone marrow and renal function.\n\nPotential Side Effects of VOLANE SOURCE 450\nLike any potent antiviral medication, VOLANE SOURCE 450 can cause side effects. Awareness and timely reporting to a healthcare provider are important to manage these effects safely.\n\nCommon side effects include:\n\nGastrointestinal symptoms: Nausea, vomiting, diarrhea, and abdominal pain.\n\nBone marrow suppression: Leading to anemia, neutropenia (low neutrophils), or thrombocytopenia (low platelets), which increase infection risks and bruising.\n\nHeadache and fatigue: Mild to moderate headache and tiredness may occur.\n\nFever and infections: Due to immune suppression, secondary infections may arise.\n\nElectrolyte imbalance: Occasionally, abnormalities in blood calcium or potassium levels.\n\nRare hypersensitivity reactions: Skin rash, itching, or swelling which require immediate medical attention.\n\nPrecautions and Contraindications\nPatients with severe renal impairment require dose adjustments or alternative therapies to avoid toxicity.\n\nPregnant or breastfeeding women should avoid this drug due to potential harm to the fetus or infant.\n\nRegular blood tests are necessary to monitor for hematologic or renal side effects.\n\nUse caution in patients with pre-existing neutropenia or anemia.\n\nConclusion\nVOLANE SOURCE 450 (Valganciclovir Tablet IP 450 mg) represents a reliable and efficacious antiviral therapy specifically targeting cytomegalovirus infections. Its role in treatment and prevention of CMV-related diseases, especially among immunocompromised patients, makes it invaluable in clinical practice.\n\nIts oral formulation allows for easy administration and effective drug delivery, improving patient adherence and outcomes. While the risk of side effects exists, careful monitoring and adherence to prescribed dosages minimize complications.\n\nOverall, VOLANE SOURCE 450 offers a potent solution against serious viral infections, helping preserve health, prevent complications, and improve quality of life for vulnerable patient populations.\n\n", "price": 3944.0, "discountamount": 2367.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "viral DNA", "rare cases", "Key Benefits", "CMV Retinitis", "VOLANE SOURCE", "CMV infection", "various organs", "kidney function", "prescribed course", "chain termination", "active ingredient", "organ transplants", "medical condition", "blood cell counts", "healthcare provider", "severe side effects", "Common Side Effects", "Regular blood tests", "complete eradication", "antiviral medication", "high bioavailability", "severe eye infection", "Serious Side Effects", "high-risk individuals", "convenient oral option", "bone marrow suppression", "weakened immune systems", "VALGANCICLOVIR TABLET IP", "High Oral Bioavailability", "Immediate medical attention" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1950, "imageuri": "https://productimages.withfloats.com/actual/6936b55236477d52c1e94700.png", "tileimageuri": "https://productimages.withfloats.com/tile/6936b55236477d52c1e94700.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-09-03T10:05:06.943Z", "updatedon": "2026-03-12T06:40:40.942Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//valganciclovir-tablet-450-mg/1950", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VOLANE SOURCE 450", "category": "CARDIOLOGYRANGE", "tags": [ "VALGANCICLOVIR TABLET IP 450 MG USUE", "Valganciclovir Tablet IP 450 mg", "infections caused by cytomegalovirus (CMV).", "VOLANE SOURCE 450", "helps control the spread of the CMV infection within the body", "high bioavailability", "improve quality of life for vulnerable patient populations", "valganciclovir tablet 450 mg uses", "valganciclovir 450 mg tablet price in India", "valganciclovir 450 mg dosage information", "valganciclovir tablet 450 mg composition", "valganciclovir 450 mg tablet side effects", "valganciclovir 450 mg tablet benefits", "what is valganciclovir tablet 450 mg used for", "how valganciclovir 450 mg works", "valganciclovir 450 mg tablet mechanism of action", "valganciclovir tablet 450 mg storage instructions", "valganciclovir 450 mg tablet administration guide", "buy valganciclovir 450 mg tablet online", "valganciclovir 450 mg tablet supplier India", "valganciclovir tablet 450 mg wholesale price", "valganciclovir 450 mg tablet manufacturer", "valganciclovir 450 mg tablet distributor", "valganciclovir 450 mg generic tablet", "valganciclovir 450 mg tablet substitute", "valganciclovir 450 mg antiviral tablet", "when to take valganciclovir 450 mg tablet" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6662b0528ecffe165c354a72", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "N Acetylecystine 150mg + Taurine 500mg", "description": "STYLETAURINE\nN Acetylecystine 150mg + Taurine 500mg\nTacrenolime 0.50 is a medication that comes in the form of Tacrolimus Capsules, with each capsule containing 0.5mg of Tacrolimus. Tacrolimus is an immunosuppressant drug that is commonly used to prevent rejection after organ transplantation. It works by suppressing the immune system's response to foreign substances, thereby reducing the risk of the body rejecting a transplanted organ.\n\nTacrolimus capsules are typically prescribed as part of a comprehensive transplant treatment regimen. The dosage and frequency of administration are determined by your healthcare provider based on factors such as your medical condition, response to treatment, and other medications you may be taking.\n\nIt's important to follow your doctor's instructions carefully when taking Tacrenolime 0.50. Do not adjust the dosage or stop taking the medication without consulting your healthcare provider. Missing doses or discontinuing treatment abruptly can increase the risk of transplant rejection or other complications.\n\nCommon side effects of Tacrenolime 0.50 may include nausea, vomiting, diarrhea, headache, dizziness, and changes in kidney function. Inform your doctor if you experience any persistent or severe side effects while taking this medication.\n\nTacrenolime 0.50 is an essential part of post-transplant care, helping to ensure the success of the transplant and improve long-term outcomes. Always keep your healthcare provider informed about any changes in your health or medications while using Tacrenolime 0.50. For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nOrder Now: \nhttps://www.sterisonline.com/product/styletaurine-133682\n\n\n\n\n\n\n", "price": 195.0, "discountamount": 59.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "form", "Call", "risk", "body", "0.5mg", "Email", "Order", "dosage", "doctor", "nausea", "success", "changes", "factors", "vomiting", "diarrhea", "headache", "WhatsApp", "response", "frequency", "dizziness", "persistent", "Tacrenolime", "sterispharma", "instructions", "sterisonline", "STYLETAURINE", "immune system", "Missing doses", "essential part", "administration", "kidney function", "N Acetylecystine", "other medications", "medical condition", "long-term outcomes", "foreign substances", "Tacrolimus Capsules", "Common side effects", "severe side effects", "healthcare provider", "other complications", "post-transplant care", "transplant rejection", "organ transplantation", "immunosuppressant drug", "comprehensive transplant treatment regimen" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1497, "imageuri": "https://productimages.withfloats.com/actual/6662b05d637f8700d7cb02a4.png", "tileimageuri": "https://productimages.withfloats.com/tile/6662b05d637f8700d7cb02a4.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T07:01:38.891Z", "updatedon": "2026-03-13T05:44:57.644Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//n-acetylecystine-150mg-taurine-500mg/1497", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "STYLETAURINE", "category": "NEPHROLOGYRANGE", "tags": [ "STYLETAURINE", "N Acetylecystine 150mg", "Taurine 500mg", "n-acetylcysteine & taurine tablets brands", "N Acetylcysteine and Taurine tablets dose", "Tazytyl Uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6662ada77247ae19c482b06f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TACRENOLIME 0.50", "description": "TACRENOLIME 0.50\nTacrolimus Capsules (0.5mg)\nTacrenolime 0.50 is a medication that comes in the form of Tacrolimus Capsules, with each capsule containing 0.5mg of Tacrolimus. Tacrolimus is an immunosuppressant drug that is commonly used to prevent rejection after organ transplantation. It works by suppressing the immune system's response to foreign substances, thereby reducing the risk of the body rejecting a transplanted organ.\n\nTacrolimus capsules are typically prescribed as part of a comprehensive transplant treatment regimen. The dosage and frequency of administration are determined by your healthcare provider based on factors such as your medical condition, response to treatment, and other medications you may be taking.\n\nIt's important to follow your doctor's instructions carefully when taking Tacrenolime 0.50. Do not adjust the dosage or stop taking the medication without consulting your healthcare provider. Missing doses or discontinuing treatment abruptly can increase the risk of transplant rejection or other complications.\n\nCommon side effects of Tacrenolime 0.50 may include nausea, vomiting, diarrhea, headache, dizziness, and changes in kidney function. Inform your doctor if you experience any persistent or severe side effects while taking this medication.\n\nTacrenolime 0.50 is an essential part of post-transplant care, helping to ensure the success of the transplant and improve long-term outcomes. Always keep your healthcare provider informed about any changes in your health or medications while using Tacrenolime 0.50.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nOrder Now: \n\nhttps://www.sterisonline.com/product/tacrenolime-0-50-133685", "price": 224.0, "discountamount": 68.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "body", "Call", "form", "risk", "Order", "0.5mg", "Email", "dosage", "doctor", "nausea", "success", "changes", "factors", "vomiting", "diarrhea", "headache", "WhatsApp", "response", "frequency", "dizziness", "persistent", "TACRENOLIME", "sterispharma", "instructions", "sterisonline", "Missing doses", "immune system", "administration", "essential part", "kidney function", "medical condition", "other medications", "long-term outcomes", "foreign substances", "other complications", "Tacrolimus Capsules", "healthcare provider", "severe side effects", "Common side effects", "transplant rejection", "post-transplant care", "organ transplantation", "immunosuppressant drug", "comprehensive transplant treatment regimen" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1495, "imageuri": "https://productimages.withfloats.com/actual/6662ada8637f8700d7caf813.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/6662ada8637f8700d7caf813.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T06:50:15.551Z", "updatedon": "2026-03-13T05:59:48.769Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//tacrenolime-0-50/1495", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TACRENOLIME 0.50", "category": "NEPHROLOGYRANGE", "tags": [ "TACRENOLIME 0.50", "Tacrolimus Capsules (0.5mg)", "tacrolimus 0.5 mg capsule price", "tacrolimus 1 mg capsule uses", "what is tacrolimus capsules used for" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6661a73687f0960e14a2c739", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "mycophenolate sodium 360 mg", "description": "MYCOPLASM S 360 \nMycophenolate sodium 360 mg is an essential immunosuppressant medication designed to prevent organ transplant rejection, particularly for kidney, heart, and liver transplants. As the sodium salt of mycophenolic acid, it delivers 360 mg of the active moiety per tablet, providing targeted immune suppression to help patients maintain their new organs long-term. This product stands out for its enteric-coated formulation, which enhances gastrointestinal tolerability compared to other forms, making it a preferred choice in post-transplant care regimens.\n\nUses of Mycophenolate Sodium 360 mg\nMycophenolate sodium 360 mg primarily serves as a prophylactic agent against acute rejection in adult and pediatric patients receiving allogeneic renal, cardiac, or hepatic transplants. It works alongside other immunosuppressants like cyclosporine and corticosteroids to create a balanced regimen that minimizes the risk of graft loss. Clinically, it proves effective in de novo transplant recipients, where starting therapy early post-surgery significantly reduces rejection episodes. Beyond transplants, off-label applications include managing refractory autoimmune conditions such as lupus nephritis or myasthenia gravis, where immune overactivity damages tissues.\n\nThe drug targets the proliferation of T- and B-lymphocytes, key players in immune responses that can attack transplanted organs. In renal transplant patients, for instance, it helps preserve kidney function by curbing antibody-mediated rejection. Its role extends to maintenance therapy, where consistent dosing sustains immunosuppression without excessive toxicity. Healthcare providers often adjust it based on patient response and trough levels of the active metabolite, mycophenolic acid (MPA), ensuring optimal therapeutic outcomes.\n\nKey Benefits of Mycophenolate Sodium 360 mg\nMycophenolate sodium 360 mg offers several advantages that make it a cornerstone in transplant medicine. One primary benefit is its selective inhibition of lymphocyte proliferation, sparing other cell types and reducing broad-spectrum immunosuppression risks. This leads to fewer opportunistic infections compared to older agents like azathioprine. The enteric coating minimizes upper GI upset, improving patient compliance—studies show higher adherence rates with this formulation.\n\nEnhanced Graft Survival: Prolongs organ viability by effectively suppressing cell-mediated and humoral immunity, with clinical data showing reduced biopsy-proven rejection rates.\n\nImproved Tolerability: Lower incidence of nausea and diarrhea due to delayed-release technology, allowing twice-daily dosing without food restrictions.\n\nFlexible Dosing: Equivalent to 720 mg mycophenolate mofetil, but with predictable MPA exposure via enterohepatic recirculation for steady-state efficacy.\n\nPediatric Suitability: Approved for children over 2 years in renal transplants, supporting growth without compromising safety.\n\nCost-Effective Long-Term Option: Balances efficacy and side effect profile, potentially lowering overall healthcare costs from fewer rejections or hospitalizations.\n\nPatients experience better quality of life, with sustained energy levels and fewer interruptions from acute rejection crises. Its metabolism to MPA via liver glucuronidation ensures reliable pharmacokinetics, even in patients with mild renal impairment.\n\nSide Effects of Mycophenolate Sodium 360 mg\nWhile highly effective, mycophenolate sodium 360 mg carries risks typical of immunosuppressants, necessitating vigilant monitoring. Common adverse effects stem from its impact on rapidly dividing cells, particularly in the gut and bone marrow.\n\nCommon Side Effects\nGastrointestinal issues like diarrhea, nausea, vomiting, and abdominal pain, affecting up to 30-50% of users.\n\nHeadache, insomnia, and tremor, often mild and transient.\n\nInfections such as urinary tract or respiratory, due to moderated immunity.\n\nHypertension or peripheral edema, manageable with supportive care.\n\nLeukopenia or anemia, requiring periodic blood counts.\n\nSerious Side Effects\nSevere myelosuppression leading to neutropenia or thrombocytopenia, which can increase infection or bleeding risks.\n\nProgressive multifocal leukoencephalopathy (PML), a rare brain infection linked to JC virus reactivation.\n\nGastrointestinal perforation or bleeding, especially in at-risk patients.\n\nIncreased malignancy risk, including lymphoma or skin cancers, over long-term use.\n\nHypersensitivity reactions like rash or anaphylaxis.\n\nRegular complete blood counts, viral monitoring (e.g., CMV, BK virus), and skin exams mitigate these risks. Dose reductions or discontinuation may be needed if counts drop significantly.\n\nMechanism of Action\nMycophenolate sodium 360 mg rapidly hydrolyzes to mycophenolic acid (MPA), a potent, reversible, non-competitive inhibitor of inosine-5'-monophosphate dehydrogenase (IMPDH). This enzyme catalyzes the rate-limiting step in de novo guanine nucleotide synthesis, depleting guanosine nucleotides essential for T- and B-cell DNA replication. Lymphocytes, reliant on this pathway, undergo proliferation arrest, suppressing both cell-mediated immunity and antibody production.\n\nMPA also hinders glycosylation of adhesion molecules on lymphocytes and monocytes, impeding their migration to graft sites. It reduces nitric oxide production in macrophages without affecting endothelial cells, curbing inflammation. Enterohepatic recirculation of the glucuronide metabolite (MPAG) prolongs MPA exposure, enhancing efficacy. Protein binding to albumin (around 97%) ensures targeted delivery, with clearance primarily renal for the inactive form.\n\nDosage and Administration Guidelines\nStandard dosing for renal transplant is 720 mg (two 360 mg tablets) twice daily, starting within 72 hours post-surgery. Adjustments occur for hepatic or cardiac transplants, often alongside cyclosporine. Therapeutic drug monitoring of MPA AUC (area under curve) optimizes levels between 30-60 mcg·h/mL. Take on an empty stomach for best absorption, though food has minimal impact due to the coating.\n\nPrecautions and Warnings\nAvoid in pregnancy (Category D) due to teratogenicity—use contraception and regular pregnancy tests. Contraindicated in active untreated infections. Monitor for GI bleeding in ulcerative colitis patients. Drug interactions with antacids, cholestyramine, or rifampin alter MPA levels. Live vaccines are prohibited.\n\nConclusion\nMycophenolate sodium 360 mg represents a vital advancement in transplant immunosuppression, offering robust protection against rejection with a favorable benefit-risk profile. Its targeted action on lymphocytes, combined with improved GI tolerance, empowers patients to thrive post-transplant. By integrating it into comprehensive regimens with close monitoring, healthcare teams maximize graft success and patient well-being. Always consult a specialist for personalized guidance to harness its full potential safely.\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/mycoplasm-s-360-133670\n\n\n\n\n\n\n", "price": 767.0, "discountamount": 567.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "dose", "risk", "body", "part", "ORDER", "360mg", "Email", "cells", "dosage", "nausea", "vomiting", "schedule", "headache", "strength", "WhatsApp", "diarrhea", "activity", "rejection", "treatment", "infections", "supplements", "information", "MYCOPLASM S", "sterispharma", "sterisonline", "stomach pain", "blood counts", "immune system", "complications", "liver problems", "liver function", "other medications", "Regular monitoring", "medical conditions", "healthcare provider", "Common side effects", "Serious side effects", "white blood cell count", "potential drug interactions", "optimal therapeutic effects", "combination therapy regimen", "organ transplant recipients", "Mycophenolate Sodium therapy", "other immunosuppressive drugs" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1474, "imageuri": "https://productimages.withfloats.com/actual/6661a739c749b7962dbc08c6.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/6661a739c749b7962dbc08c6.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T12:10:30.488Z", "updatedon": "2026-03-12T08:02:36.733Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//mycophenolate-sodium-360-mg/1474", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MYCOPLASM S 360 ", "category": "Oncology", "tags": [ "MYCOPLASM S 360", "Mycophenolate sodium (360mg)", "Mycophenolate sodium 360 mg price", "Mycophenolate sodium 360 mg brands", "Mycophenolate sodium 360 mg side effects", "Myfortic 360 alternative", "Myfortic 500" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6661a57d8da3a81d5c6a17dd", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Mycophenolate mofetil 500mg", "description": "MYCOPLASM M 500\nMycophenolate mofetil (500mg)\nMycoplasm M 500 is a medication containing Mycophenolate Mofetil in a 500mg dose. Mycophenolate Mofetil is an immunosuppressive drug used to prevent rejection in organ transplantation, particularly kidney, heart, and liver transplants. It works by inhibiting the proliferation of T and B lymphocytes, which are involved in the immune response that leads to rejection.\n\nThis medication is typically prescribed in combination with other immunosuppressants as part of a comprehensive transplant treatment regimen. It is important to take Mycoplasm M 500 exactly as prescribed by your healthcare provider to ensure optimal therapeutic outcomes and to minimize the risk of rejection or other complications.\n\nCommon side effects of Mycophenolate Mofetil may include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal pain. It can also increase the risk of infections due to its immunosuppressive effects. Patients should be monitored regularly by their healthcare provider while taking this medication to assess for any potential adverse effects and to adjust the dosage as needed.\n\nMycoplasm M 500 should not be used in pregnant women or those planning to become pregnant without consulting a healthcare professional, as it can cause harm to the developing fetus. Additionally, it may interact with other medications, so it is important to inform your doctor about all the medications you are currently taking before starting Mycoplasm M 500 therapy.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \n\n\n\n\nMycophenolate mofetil 500 mg stands as a cornerstone in modern immunosuppressive therapy, primarily designed to prevent organ transplant rejection in kidney, heart, and liver recipients. As a prodrug, it rapidly converts to its active form, mycophenolic acid (MPA), which selectively targets the proliferation of T and B lymphocytes—key players in immune responses that can attack transplanted organs. This medication, available in convenient 500 mg tablets, offers reliable protection against acute rejection episodes, making it an essential component in post-transplant regimens worldwide.\n\nProduct Uses\nMycophenolate mofetil 500 mg finds its primary application in solid organ transplantation, where it helps maintain long-term graft survival. For kidney transplant patients, it is typically administered alongside corticosteroids and calcineurin inhibitors like cyclosporine or tacrolimus to suppress the immune system's overreaction to the new organ. In heart and liver transplants, it plays a similar role, reducing the incidence of rejection by inhibiting antibody production and cell-mediated immunity.\n\nBeyond transplants, healthcare providers increasingly use mycophenolate mofetil 500 mg for various autoimmune conditions. It effectively manages lupus nephritis by curbing inflammation in the kidneys, showing superior efficacy over traditional therapies in preserving renal function. Rheumatoid arthritis patients benefit from its ability to dampen joint inflammation, while those with dermatomyositis or scleroderma experience reduced skin and muscle involvement. Off-label, it treats inflammatory bowel diseases like Crohn's disease and even certain skin disorders such as pemphigus vulgaris, where immune-mediated blistering threatens quality of life.\n\nKey Benefits\nThe therapeutic advantages of mycophenolate mofetil 500 mg extend far beyond basic immunosuppression, offering patients enhanced outcomes and improved daily living.\n\nSuperior Graft Protection: Clinical data highlight reduced acute rejection rates by up to 50% when combined with standard regimens, leading to better long-term organ function and survival.\n\nSelective Lymphocyte Targeting: By depleting guanosine nucleotides in T and B cells via inosine monophosphate dehydrogenase (IMPDH) inhibition, it spares other cell types, minimizing broad toxicity seen with older immunosuppressants.\n\nAnti-Inflammatory Effects: MPA inhibits adhesion molecule glycosylation, preventing lymphocyte recruitment to inflamed sites, which alleviates symptoms in autoimmune flares.\n\nOral Convenience: The 500 mg formulation allows flexible dosing—typically 1 gram twice daily—without the need for injections, improving patient adherence.\n\nVersatility Across Conditions: Proven efficacy in lupus, vasculitis, and myositis expands its utility, often allowing steroid dose reduction and fewer relapses.\n\nCardiovascular and Anticancer Potential: Emerging evidence suggests it delays graft atherosclerosis by reducing lipid oxidation and may hinder tumor progression in certain malignancies due to its impact on nucleotide synthesis.\n\nThese benefits translate to fewer hospital readmissions, better quality of life, and cost savings in long-term care for transplant and autoimmune patients.\n\nSide Effects\nWhile mycophenolate mofetil 500 mg provides robust immunosuppression, it carries risks typical of this drug class, necessitating vigilant monitoring.\n\nCommon side effects affect the gastrointestinal tract most prominently, with nausea, vomiting, diarrhea, and abdominal pain occurring in over 30% of users. These often improve with dose adjustments or enteric-coated alternatives, but hydration and antiemetics help manage them effectively.\n\nHematologic issues like leukopenia, anemia, and thrombocytopenia arise due to bone marrow suppression, requiring regular complete blood counts—weekly initially, then monthly. Infections pose a significant threat, as suppressed immunity increases susceptibility to viral (e.g., CMV), bacterial, and fungal pathogens; prophylactic antivirals are standard.\n\nLess frequent but notable effects include hypertension, tremor, insomnia, and elevated liver enzymes. Women face heightened risks of congenital malformations if used during pregnancy, mandating effective contraception and pregnancy testing. Rare severe reactions encompass progressive multifocal leukoencephalopathy (PML) from JC virus reactivation and hypersensitivity syndromes.\n\nDosage and Administration Notes\nStandard dosing for renal transplants involves 1 gram (two 500 mg tablets) twice daily, starting within 72 hours post-surgery, with adjustments for renal impairment. Hepatic transplant patients may require higher initial doses due to metabolism differences. Always take on an empty stomach with water to optimize absorption, avoiding antacids that bind MPA.\n\nPrecautions and Interactions\nPatients must avoid live vaccines, report fevers promptly, and undergo TB screening pre-treatment. Drug interactions with azathioprine, cholestyramine, or rifampin can alter levels, so pharmacists review regimens closely. Regular monitoring of MPA blood levels ensures therapeutic efficacy without toxicity.\n\nConclusion\nMycophenolate mofetil 500 mg emerges as a transformative immunosuppressive agent, safeguarding transplanted organs and taming autoimmune storms with its precise mechanism of lymphocyte suppression and anti-inflammatory prowess. By delivering key benefits like reduced rejection, versatile applications, and manageable administration, it empowers patients to reclaim normalcy post-transplant or amid chronic illness. Despite potential side effects, proactive monitoring and personalized dosing mitigate risks, underscoring its value in contemporary medicine. For those navigating transplant recovery or autoimmune challenges, this medication offers hope and stability, backed by decades of clinical validation.\n\n", "price": 775.0, "discountamount": 256.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "part", "Call", "harm", "risk", "Email", "heart", "ORDER", "nausea", "kidney", "dosage", "doctor", "vomiting", "WhatsApp", "Patients", "diarrhea", "rejection", "infections", "500mg dose", "combination", "information", "sterisonline", "proliferation", "B lymphocytes", "abdominal pain", "pregnant women", "immune response", "developing fetus", "other medications", "liver transplants", "other complications", "healthcare provider", "Common side effects", "organ transplantation", "Mycophenolate mofetil", "immunosuppressive drug", "Mycoplasm M 500 therapy", "healthcare professional", "other immunosuppressants", "immunosuppressive effects", "potential adverse effects", "optimal therapeutic outcomes", "gastrointestinal disturbances", "comprehensive transplant treatment regimen" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1472, "imageuri": "https://productimages.withfloats.com/actual/6661a57fdd39d2ccddbc3bb9.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/6661a57fdd39d2ccddbc3bb9.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T12:03:09.216Z", "updatedon": "2026-03-12T08:00:39.14Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//mycophenolate-mofetil-500mg/1472", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MYCOPLASM M 500", "category": "NEPHROLOGYRANGE", "tags": [ "MYCOPLASM M 500", "Mycophenolate mofetil (500mg)", "Mycophenolate mofetil 500 mg tablet", "Mycophenolate mofetil 500 mg price", "Mycophenolate mofetil 500 mg dosage", "Mycophenolate mofetil uses", "Mycophenolate mofetil side effects", "mycophenolate mofetil 500mg tablet uses", "mycophenolate mofetil 500mg dosage for kidney transplant", "mycophenolate mofetil 500mg for autoimmune disease" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6a86e496cc4491de1ed77dfd", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Etoricoxib & Cyclobenzaprine Hydrochloride Tablets", "description": "ERITOCOX BENZ 90/5 is a fixed-dose combination tablet pairing Etoricoxib 90 mg, a selective COX-2 anti-inflammatory, with Cyclobenzaprine Hydrochloride 5 mg, a centrally acting muscle relaxant. It is prescribed for short-term relief of acute musculoskeletal problems where pain, swelling, and muscle tightness occur together — think a sudden low-back strain, a stiff neck, or a flare-up of arthritis where the surrounding muscles clamp down defensively. Rather than treating the inflammation alone or the spasm alone, this tablet addresses both mechanisms in one dose, which can mean fewer pills and a more complete response for short, acute episodes. It is a prescription-only (Schedule H) medicine, produced under WHO-GMP and ISO-certified manufacturing standards by Steris Healthcare Pvt. Ltd. Typical side effects include drowsiness, dry mouth, and mild stomach upset; because the combination carries cardiovascular, gastrointestinal, and kidney considerations, it should only be used under a doctor's supervision. This page walks through what the tablet does, how it works, correct usage, safety information, and answers to the questions people most often ask.\n\nWhat Is ERITOCOX BENZ 90/5?\n\nPain from an acute back injury, a wrenched neck, or an arthritis episode almost never travels alone — it tends to bring a tense, guarded muscle along with it that makes every movement feel worse. ERITOCOX BENZ 90/5 was formulated with that pattern in mind, folding two separate mechanisms into a single tablet rather than requiring two prescriptions.\n\nActive Ingredient\tStrength\tRole\nEtoricoxib\t90 mg\tSelective COX-2 inhibitor for inflammatory pain\nCyclobenzaprine Hydrochloride\t5 mg\tCentrally acting skeletal muscle relaxant\n\nEach tablet is manufactured by Steris Healthcare Pvt. Ltd., a WHO-GMP and ISO-certified pharmaceutical company, so every batch meets verified potency and quality benchmarks.\n\nWhy This Combination Makes Sense\n\nMusculoskeletal pain is rarely a single-track problem. When tissue is injured or irritated, inflammation flares up locally — and nearby muscles frequently respond by tightening protectively. That protective tightening, the spasm, often becomes a pain generator of its own. Treat only the inflammation and the spasm can linger; treat only the spasm and the underlying inflammation keeps driving discomfort.\n\nERITOCOX BENZ 90/5 is built to intervene on both fronts at once:\n\nEtoricoxib addresses the chemical cascade responsible for pain and swelling at the injured site.\nCyclobenzaprine works through the central nervous system to calm the muscle guarding that so often rides alongside that pain.\nMechanism of Action: How ERITOCOX BENZ 90/5 Works\n\nEtoricoxib selectively inhibits the COX-2 enzyme — the enzyme the body ramps up at sites of tissue damage or irritation to manufacture prostaglandins, the chemical messengers behind pain, swelling, and localized heat. Because it targets COX-2 specifically rather than blocking both COX-1 and COX-2 the way older, non-selective NSAIDs do, etoricoxib is designed to control inflammatory pain while leaving more of the COX-1 activity that protects the stomach lining relatively undisturbed.\n\nCyclobenzaprine Hydrochloride takes a different route entirely — its primary site of action is the brainstem, not the muscle fiber itself. By dampening excessive motor signaling sent to skeletal muscle, it reduces spasm and stiffness without producing the broad muscle weakness that a directly-acting muscle agent might cause.\n\nPut together, the tablet delivers a two-pronged effect: peripheral anti-inflammatory action from etoricoxib, layered with central muscle relaxation from cyclobenzaprine.\n\n[Reviewer placeholder: insert verified pharmacokinetic data (onset, half-life, bioavailability) once confirmed by medical/regulatory team — do not publish unverified figures.]\n\nClinical Uses of ERITOCOX BENZ 90/5\n\nA physician may prescribe this combination for short-term management of acute conditions where pain, inflammation, and spasm show up together, including:\n\nCondition\tTypical Presentation\nAcute lower back pain\tPain with associated muscle guarding/spasm\nNeck strain / cervical spasm\tStiff, restricted neck movement\nSprains, strains, overuse injuries\tMusculoskeletal trauma with inflammatory pain\nOsteoarthritis flare-ups\tJoint pain accompanied by surrounding muscle tightness\nPostural or occupational muscle pain\tWork- or posture-related inflammation and tension\nMovement restriction linked to spasm\tReduced range of motion driven by muscular guarding\n\nSuitability for any of the above must be confirmed by a doctor based on your specific diagnosis and medical history.\n\nKey Benefits of ERITOCOX BENZ 90/5\nOne tablet, two mechanisms — anti-inflammatory pain relief and muscle-spasm relief combined, simplifying an otherwise two-drug regimen.\nSite-focused inflammation control — etoricoxib's COX-2 selectivity is intended to concentrate its effect where inflammation is actually active.\nA comparatively gentler GI footprint — COX-2-selective action is generally linked to lower gastrointestinal irritation risk than older non-selective NSAIDs, though vigilance is still warranted.\nLoosens spasm-related stiffness — cyclobenzaprine's central action helps release tight, guarded muscles restricting movement.\nAids functional recovery — easing both pain and spasm can make it more realistic to resume light activity, stretching, or physiotherapy once your doctor clears you.\nStreamlined short-course dosing — a once-daily schedule (as prescribed) cuts down pill burden versus taking an NSAID and a muscle relaxant separately.\nDosage & Administration\n\nThe following is general reference information — your doctor's specific prescription always takes precedence.\n\nTake ERITOCOX BENZ 90/5 exactly as prescribed, generally once a day, with or without food.\nSwallow the tablet whole with water; avoid crushing or chewing unless your doctor tells you otherwise.\nTreatment is typically short — anywhere from a few days to roughly two weeks — reflecting the acute, self-limiting nature of most pain-and-spasm episodes.\nIf a dose is missed, take it as soon as you remember, but skip it entirely if the next dose is nearly due. Never double up to make up for a missed dose.\nDo not extend the treatment period or adjust your dose independently, even if symptoms haven't fully resolved.\nSide Effects of ERITOCOX BENZ 90/5\nCommon Side Effects\nDrowsiness or sleepiness\nDizziness\nDry mouth\nHeadache\nStomach discomfort or indigestion\nNausea\nFatigue\nMild elevation in blood pressure in some individuals\nSerious Side Effects — Seek Medical Help Promptly\nSigns of gastrointestinal bleeding, such as black stools or vomiting blood\nA severe allergic reaction — swelling of the face or throat, breathing difficulty, or widespread rash\nChest pain, irregular heartbeat, or other symptoms suggestive of a cardiovascular event\nYellowing of the skin or eyes, which may point to liver involvement\nA noticeable drop in urine output, which may suggest kidney impairment\nSevere dizziness, confusion, or fainting\n\nIf any of these serious symptoms appear, stop the medicine and get medical attention immediately.\n\nPrecautions & Warnings\nShare your full medical history with your doctor before starting, including any heart, kidney, or liver conditions.\nUse cautiously — or avoid altogether — if you have a history of stomach ulcers or gastrointestinal bleeding.\nGenerally not advised for people with uncontrolled high blood pressure, existing heart disease, or a prior stroke, unless a doctor specifically clears its use.\nSteer clear of alcohol, since it can amplify cyclobenzaprine's sedative effect and add to gastrointestinal risk.\nCyclobenzaprine may cause drowsiness or dizziness — hold off on driving or operating machinery until you know how the tablet affects you.\nDon't combine ERITOCOX BENZ 90/5 with other NSAIDs, painkillers, or sedating medicines without checking with your doctor first.\nAvoid the medicine if you have known hypersensitivity to etoricoxib, cyclobenzaprine, or related compounds.\nNot generally recommended during pregnancy or breastfeeding unless a doctor specifically advises otherwise.\nAvoid combining with MAO inhibitors, or using shortly after stopping them.\nDrug Interactions to Flag With Your Doctor\n\nDisclose every prescription medicine, over-the-counter product, and supplement you take. Extra caution is needed around medicines affecting:\n\nBlood pressure regulation\nKidney function\nBlood clotting\nCentral nervous system activity (sedatives, other muscle relaxants)\nLiver metabolism\nOther anti-inflammatory or pain-relief medicines\nConclusion\n\nERITOCOX BENZ 90/5 brings Etoricoxib 90 mg and Cyclobenzaprine Hydrochloride 5 mg together to tackle a problem that rarely presents as a single issue — pain, inflammation, and muscle spasm that reinforce one another in acute musculoskeletal conditions. By acting on both the inflammatory and muscular sides of that cycle, it offers a more rounded short-term response than either ingredient could provide alone.\n\nGiven the genuine cardiovascular, gastrointestinal, kidney, and central-nervous-system considerations involved, ERITOCOX BENZ 90/5 is meant strictly for short, doctor-supervised courses — not casual or extended self-treatment. Always check with your doctor to confirm whether this combination is right for your condition, medical history, and current medications.\n\nPrescription only – consult your doctor.\n\nFrequently Asked Questions (Google & AI Mode / Voice Search Optimized)\n\n1. What is ERITOCOX BENZ 90/5 used for? It's typically prescribed for short-term relief of acute musculoskeletal issues — such as back pain, neck strain, or an arthritis flare-up — where pain, inflammation, and muscle spasm show up together.\n\n2. Is ERITOCOX BENZ 90/5 a muscle relaxant? It's a combination tablet: the muscle-relaxing effect comes from its Cyclobenzaprine Hydrochloride component, while Etoricoxib supplies the pain-relieving, anti-inflammatory action.\n\n3. Is Etoricoxib a strong painkiller? Etoricoxib is an effective selective COX-2 inhibitor typically used for moderate inflammation-related pain, such as arthritis or an acute musculoskeletal injury. Its appropriateness for your level of pain should be assessed by a doctor.\n\n4. Is Etoricoxib safe for the kidneys? As with other NSAIDs, etoricoxib can influence kidney function, particularly with extended use, higher doses, dehydration, or existing kidney disease. It should be used carefully and only under medical guidance if kidney health is a concern.\n\n5. Should ERITOCOX BENZ 90/5 be taken in the morning or at night? It's usually taken once a day at a time your doctor sets. Since cyclobenzaprine can cause drowsiness, many doctors lean toward an evening dose — but always stick to your specific prescription.\n\n6. What are the common side effects of ERITOCOX BENZ 90/5? Frequently reported effects include drowsiness, dizziness, dry mouth, headache, stomach discomfort, and mild fatigue. Most fade on their own, but persistent symptoms should be reported to your doctor.\n\n7. How fast does ERITOCOX BENZ 90/5 start working? Etoricoxib tends to absorb fairly quickly, and many people feel pain relief within roughly an hour, though onset can vary by individual and whether the tablet is taken with food.\n\n8. What should be avoided while on ERITOCOX BENZ 90/5? Skip alcohol, avoid taking other NSAIDs or painkillers without medical advice, and hold off on driving or operating machinery if you're feeling drowsy or dizzy.\n\n9. How many days can ERITOCOX BENZ 90/5 be taken? It's usually prescribed for a short stretch — a few days up to around two weeks — matching how acute conditions typically resolve. Anything longer needs your doctor's review.\n\n10. What are the benefits of ERITOCOX BENZ 90/5? It delivers combined relief from pain, inflammation, and muscle spasm in one tablet, which can make it easier to move normally and get back to daily activity sooner when used as directed.\n\n11. How safe is ERITOCOX BENZ 90/5? Taken exactly as prescribed and for the recommended duration, it's generally considered safe for most adults. It does carry cardiovascular, gastrointestinal, kidney, and liver-related risks that call for medical supervision, especially if you already have related conditions.\n\n12. Can ERITOCOX BENZ 90/5 be used for knee pain? Yes — its etoricoxib component is commonly used for joint pain tied to osteoarthritis or an acute injury, including the knee, by reducing the underlying inflammation. A doctor should confirm suitability first.\n\n13. Does ERITOCOX BENZ 90/5 cause drowsiness? Yes — drowsiness and dizziness are known effects linked to its cyclobenzaprine component. Avoid driving or tasks requiring full alertness until you know how it affects you.\n\n14. Can ERITOCOX BENZ 90/5 be bought without a prescription? No. This is a prescription-only medicine meant to be taken solely under a qualified doctor's supervision — it isn't meant for self-prescribing or extended use without medical oversight.\n\n15. Can ERITOCOX BENZ 90/5 be taken with food? It can generally be taken with or without food, though taking it with food may ease stomach discomfort for some people. Follow your doctor's specific instructions.\n\n16. Is ERITOCOX BENZ 90/5 habit-forming? Cyclobenzaprine isn't considered addictive with typical short-term use, but the tablet should still be taken only for the prescribed duration and not restarted on your own without medical advice.\n\n17. Who should avoid taking ERITOCOX BENZ 90/5? People with active stomach ulcers, significant heart, kidney, or liver disease, known hypersensitivity to NSAIDs, or those who are pregnant or breastfeeding should avoid it unless a doctor specifically clears its use.", "price": 222.0, "discountamount": 67.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2495, "imageuri": "https://productimages.withfloats.com/actual/6a86e4990f089c4695c57658.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a86e4990f089c4695c57658.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-20T11:27:18.403Z", "updatedon": "2026-08-20T11:27:18.403Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//etoricoxib-cyclobenzaprine-hydrochloride-tablets/2495", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ERITOCOX BENZ 90/5", "category": "", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }

This is your website preview.

Everolimus Tablets 0.5 m

RIBAVIRIN CAPSULES IP 10

Ursodeoxycholic Acid 600

VALGANCICLOVIR TABLET 4

N Acetylecystine 150mg +

TACRENOLIME 0.50

mycophenolate sodium 360

Mycophenolate mofetil 50

Etoricoxib & Cyclobenzap

Still searching for
post transplant care?

Still searching for
post transplant care?

Opening Hours

Subscribe to our newsletter!

Social share

This is your website preview.